Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 20Squamous Cell Carcinoma of Head and Neck 19Esophageal Neoplasms 19Head and Neck Neoplasms 13Nasopharyngeal Carcinoma 12Uterine Cervical Neoplasms 11Pancreatic Neoplasms 9Oropharyngeal Neoplasms 8Lung Neoplasms 7Glioblastoma 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Squamous Cell 6Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Mouth Neoplasms 4Hypopharyngeal Neoplasms 4Colorectal Neoplasms 4Carcinoma 4Adenocarcinoma 4Radiation Injuries 3Pathologic Complete Response 3Laryngeal Neoplasms 3Breast Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms by Site 2Nasopharyngeal Neoplasms 2NSCLC 2

Interventions

durvalumab 2Radiotherapy 2Etoposide 2Drug Therapy 2Cisplatin 2trilaciclib 1tislelizumab 1pamiparib 1anlotinib 1Tirapazamine 1Surgical Procedures, Operative 1Sodium Chloride 1Radiation Dose Hypofractionation 1Radiation 1Probiotics 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Glucose 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × Chemoradiotherapy × Clear all
NCT04952597 2024-10-26

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

BeiGene

Phase 2 Completed
126 enrolled 19 charts
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡